ATANIS Biotech AG reposted this
Associate Professor at University of Bern, Immunologist, Allergy & Aging Researcher, Entrepreneur
Developing a novel cell-based diagnostic test that performs reliably is no easy task. It requires rigorous validation in a real-world patient cohort, with appropriate controls and blinded assessments. Demonstrating its clinical utility against current state-of-the-art diagnostics with favorable outcomes is the true measure of success. I'm excited to share that we've achieved all of the above with our Hoxb8 mast cell activation test #Hoxb8MAT in our recent study on peanut allergy diagnosis, now published in Allergy EAACI. A big thank you to our collaborators from The Hospital for Sick Children in Toronto, Canada who made this possible! Next steps - to make this exciting test available to clinicians & patients in an #IVDR/ FDA certified manner! #GoalsFor2025 Thomas Eiwegger, Thomas Kaufmann, Julia Upton, Noemi Bachmeier-Zbären, Rosa Robin van Brummelen, Alper Celik, Melanie Steinmann, Nadine Roos, University of Bern, Department for BioMedical Research DBMR, Lung Precision Medicine (LPM) DBMR Bern, The Hospital for Sick Children, ATANIS Biotech AG, Jean-Pierre Kinet, FARE, Innovation Office University of Bern, European Academy of Allergy and Clinical Immunology - EAACI, Rheumatologie_Immunologie Bern
Erwan Eriau
1w
Great to see all the hard work pay off!
Great - congratulations Alexander and Team, for this important step to improve Allergy diagnosis!
Congrats, Alex and team! Very exciting progress.
Congrats Alexander!
Congrats Alexander!
Thank you for your contributions to the field of allergy.